Market cap and P/E at the last close; sales growth is the latest quarter on the same quarter a year before; ROE for the latest financial year.
From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.
In ₹ Crore except Per Share Latest Annual | PINELABS FY26 | PAYTM FY26 | NUVAMA FY26 | STARHEALTH FY26 | Peer Average | |
|---|---|---|---|---|---|---|
| Valuation — at last close | ||||||
| P/E | 156.39× | 194.75× | ◆ 30.98× | 56.22× | 93.98× +66% | |
| P/B | ◆ 3.20× | 6.73× | 7.88× | 4.13× | 6.25× -49% | |
| EV/EBITDA | 30.44× | 185.95× | ◆ 9.03× | 42.52× | 79.17× -62% | |
| Market Cap | ₹18,856 Cr | ₹1.08L Cr | ₹32,476 Cr | ₹31,313 Cr | ₹57,242 Cr -67% | |
| Growth | ||||||
| Revenue CAGR 3Y | — | 1.83% | ◆ 27.87% | — | 14.85% | |
| Net Income CAGR 3Y | — | — | 50.52% | — | 50.52% | |
| Revenue YoY (latest Q) | 24.05% | ◆ 28.48% | 22.59% | — | 25.54% -6% | |
| Net Income YoY (latest Q) | 546.06% | ◆ 971.43% | 15.83% | 382.35% | 456.54% +20% | |
| Profitability | ||||||
| EBITDA Margin | 13.23% | 5.95% | ◆ 52.72% | — | 29.34% -55% | |
| Net Income Margin | 4.15% | 6.54% | ◆ 22.46% | — | 14.50% -71% | |
| Return on Common Equity | 1.91% | 3.56% | ◆ 27.36% | 7.62% | 12.85% -85% | |
| Return on Capital Employed | 1.45% | -0.42% | — | ◆ 26.73% | 13.15% -89% | |
| Return on Assets | 0.85% | 2.43% | 3.31% | ◆ 7.14% | 4.29% -80% | |
| Credit & Quality | ||||||
| Total Debt/Equity | 0.05× | ◆ 0.00× | 2.80× | 0.06× | 0.95× -95% | |
| Interest Coverage | 1.05× | -3.67× | ◆ 2.38× | — | -0.65× +263% | |
| Scale — latest FY | ||||||
| Revenue / Total Income | ₹2,711 Cr | ₹8,437 Cr | ₹4,631 Cr | — | ₹6,534 Cr -59% | |
| Net Income | ₹113 Cr | ₹552 Cr | ₹1,040 Cr | ₹557 Cr | ₹716 Cr -84% | |
| Total Assets | ₹13,297 Cr | ₹23,915 Cr | ₹34,491 Cr | ₹8,021 Cr | ₹22,142 Cr -40% | |
| EPS | ₹1.05 | ₹8.66 | ₹57.59 | ₹9.47 | ₹25.24 -96% | |
| Book Value per Share | ₹51.34 | ₹250.41 | ₹226.36 | ₹129.04 | ₹201.94 -75% | |